NYSE:TDOC - Teladoc Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$71.07 +0.20 (+0.28 %)
(As of 10/17/2018 11:38 AM ET)
Previous Close$70.87
Today's Range$69.93 - $71.88
52-Week Range$27.30 - $89.05
Volume32,953 shs
Average Volume1.28 million shs
Market Capitalization$6.01 billion
P/E Ratio-43.21
Dividend YieldN/A
Beta0.57
Teladoc Health, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
SymbolNYSE:TDOC
CUSIPN/A
Phone203-635-2002

Debt

Debt-to-Equity Ratio0.58
Current Ratio3.14
Quick Ratio3.14

Price-To-Earnings

Trailing P/E Ratio-43.21
Forward P/E Ratio-47.07
P/E GrowthN/A

Sales & Book Value

Annual Sales$233.28 million
Price / Sales21.19
Cash FlowN/A
Price / CashN/A
Book Value$9.80 per share
Price / Book7.25

Profitability

EPS (Most Recent Fiscal Year)($1.65)
Net Income$-106,780,000.00
Net Margins-37.78%
Return on Equity-19.10%
Return on Assets-11.57%

Miscellaneous

Employees1,231
Outstanding Shares69,540,000
Market Cap$6.01 billion

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc Health's earnings last quarter?

Teladoc Health Inc (NYSE:TDOC) announced its earnings results on Wednesday, August, 1st. The health services provider reported ($0.37) earnings per share for the quarter, beating analysts' consensus estimates of ($0.38) by $0.01. The health services provider had revenue of $94.60 million for the quarter, compared to analyst estimates of $91.56 million. Teladoc Health had a negative net margin of 37.78% and a negative return on equity of 19.10%. The company's revenue for the quarter was up 112.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.28) EPS. View Teladoc Health's Earnings History.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release their next quarterly earnings announcement on Thursday, November 1st 2018. View Earnings Estimates for Teladoc Health.

How can I listen to Teladoc Health's earnings call?

Teladoc Health will be holding an earnings conference call on Thursday, November 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8332414255.

What price target have analysts set for TDOC?

19 analysts have issued twelve-month target prices for Teladoc Health's shares. Their forecasts range from $45.00 to $100.00. On average, they anticipate Teladoc Health's stock price to reach $81.9474 in the next year. This suggests a possible upside of 16.5% from the stock's current price. View Analyst Price Targets for Teladoc Health.

What is the consensus analysts' recommendation for Teladoc Health?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 4 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teladoc Health.

What are Wall Street analysts saying about Teladoc Health stock?

Here are some recent quotes from research analysts about Teladoc Health stock:
  • 1. Canaccord Genuity analysts commented, "We remain confident in our above-consensus estimate (~22k) for Q2 unit sales, as web traffic trends and used car market strength suggest CVNA continues to generate healthy gains in consumer mindshare. Moreover, third-party data (including transactional inputs from DataWeave) imply unit sales above consensus and our estimates. While Q3 guidance is somewhat of a wildcard (early signals are positive) we continue to like shares at current levels. Reiterate Outperform rating." (8/2/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on TDOC shares and raise our 12-month price target to $52 from $50. On August 1, TDOC reported 2Q18 results. Revenue was above our estimate and FactSet consensus. Adjusted EBITDA was ahead of consensus expectations as well. The company raised its 2018 guidance to reflect the acquisition of Advance Medical, recognizing the TRICARE launch is slightly delayed. Revenue grew 112%, or 39% organically. We continue to believe that TDOC is positioned to benefit from solid telehealth growth, but that the shares’ current valuation already reflects the strong growth potential." (8/1/2018)
  • 3. According to Zacks Investment Research, "The stock of Teladoc has outperformed the industry year to date. The company is witnessing steady business growth with insurers and customers increasingly embracing telehealth. It’s organic growth initiative remains on track. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. Also the company boasts an impressive clientele. The company has also provided strong guidance for 2017. The company has incurred significant losses in each period since its inception in 2002. Teladoc has been unable to generate cash from operations and we have doubts over its ability to do so in the coming quarters. Its high debt level has caused a spike in interest expense which has dented its operating margins." (10/18/2017)

Are investors shorting Teladoc Health?

Teladoc Health saw a drop in short interest in August. As of August 31st, there was short interest totalling 15,552,436 shares, a drop of 14.4% from the August 15th total of 18,167,305 shares. Based on an average daily volume of 1,213,506 shares, the short-interest ratio is presently 12.8 days. Approximately 25.3% of the shares of the company are sold short. View Teladoc Health's Current Options Chain.

Who are some of Teladoc Health's key competitors?

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the folowing people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 46)
  • Mr. Peter A. McClennen, Pres (Age 49)
  • Mr. Mark J. Hirschhorn, Exec. VP, COO & CFO (Age 53)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 43)
  • Dr. Lewis Levy M.D., FACP, Chief Medical Officer (Age 59)

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.21%), Bainco International Investors (0.20%), Barometer Capital Management Inc. (0.11%), Jaffetilchin Investment Partners LLC (0.04%), Legacy Capital Partners Inc. (0.04%) and Daiwa SB Investments Ltd. (0.04%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Jason N Gorevic, Lewis Levy, Lp Chp III, Mark Hirschhorn, Michael Goldstein, Michael H King, Peter A Mcclennen, Stephany Verstraete and Trident Capital Fund Vi Lp. View Institutional Ownership Trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Bainco International Investors, Riverbridge Partners LLC, Daiwa SB Investments Ltd., NJ State Employees Deferred Compensation Plan, Legacy Capital Partners Inc. and Jaffetilchin Investment Partners LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Peter A Mcclennen and Stephany Verstraete. View Insider Buying and Selling for Teladoc Health.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was purchased by a variety of institutional investors in the last quarter, including Barometer Capital Management Inc., Bank of Montreal Can, Atria Investments LLC and We Are One Seven LLC. View Insider Buying and Selling for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $70.34.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $6.01 billion and generates $233.28 million in revenue each year. The health services provider earns $-106,780,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis. Teladoc Health employs 1,231 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is http://www.teladoc.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]


MarketBeat Community Rating for Teladoc Health (NYSE TDOC)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  412 (Vote Outperform)
Underperform Votes:  221 (Vote Underperform)
Total Votes:  633
MarketBeat's community ratings are surveys of what our community members think about Teladoc Health and other stocks. Vote "Outperform" if you believe TDOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel